Article
Biochemical characterization of two novel mutations in the human high-affinity choline transporter 1 identified in a patient with congenital myasthenic syndrome.
Human molecular genetics - 20 Apr 2023
Rizvi Midhat, Truong Tina K, Zhou Janet, Batta Manav, Moran Ellen S, Pappas John, Chu Mary Lynn, Caluseriu Oana, Evrony Gilad D, Leslie Elaine M, Cordat Emmanuelle
Abstract excerpt
Congenital myasthenic syndrome (CMS) is a heterogeneous condition associated with 34 different genes, including SLC5A7, which encodes the high-affinity choline transporter 1 (CHT1). CHT1 is expressed in presynaptic neurons of the neuromuscular junction where it uses the inward sodium gradient to reuptake choline. Biallelic CHT1 mutations often lead to neonatal lethality, and less commonly to non-lethal motor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
